Diagnostic methods and emerging treatments for adult neuronal ceroid lipofuscinoses (Kufs disease)

Francesca Magrinelli, Francesco Pezzini, Francesca Moro, Filippo M. Santorelli, Alessandro Simonati

Research output: Contribution to journalReview article

1 Citation (Scopus)

Abstract

Introduction: Adult-onset neuronal ceroid lipofuscinoses (ANCL) are a group of rare inherited neurodegenerative diseases of early adulthood, named after the presence of intralysosomal autofluorescent lipopigment with characteristic ultrastructural features in neurons and other cell types. Over the last decade, six ANCL genes have been identified, three of them being related to exclusively adult-onset phenotypes, the remaining three shared with childhood-onset NCL (CNCL). Areas covered: Even in the molecular era, the contribution of neuropathological assessment is essential since genetic heterogeneity foresees new genes to be detected and validated. No disease-modifying therapy (DMT) is available for neuronal ceroid lipofuscinoses (NCL), but patients may benefit from improved symptomatic and supportive treatments, and recent advances in cellular and molecular biology (utilizing both cellular and animal models of the disease) have provided important contributions to the knowledge of NCL pathophysiology. DMT strategies aim to prevent storage formation and/or deplete accumulated substrate; few of them have already been translated into clinical practice in CNCL only. Expert opinion: The complexity of pathophysiological mechanisms underlying NCL, such as neuronal excitotoxicity, unfavourable condition of the neuropil and enhanced vulnerability of the affected cells, requires the identification of multiple targets suitable for treatments to prevent neuronal progressive dysfunction and death.

Original languageEnglish
Pages (from-to)487-501
Number of pages15
JournalExpert Opinion on Orphan Drugs
Volume5
Issue number6
DOIs
Publication statusPublished - Jun 3 2017

Fingerprint

Neuronal Ceroid-Lipofuscinoses
Therapeutics
Animal Disease Models
Neuropil
Genetic Heterogeneity
Expert Testimony
Neurodegenerative Diseases
Genes
Cell Biology
Molecular Biology
Phenotype
Neurons

Keywords

  • Adult-onset neuronal ceroid lipofuscinosis
  • ANCL diagnosis
  • NCL
  • neuropathology
  • Parry disease
  • therapeutic strategies
  • treatment

ASJC Scopus subject areas

  • Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
  • Health Policy
  • Pharmacology (medical)

Cite this

Diagnostic methods and emerging treatments for adult neuronal ceroid lipofuscinoses (Kufs disease). / Magrinelli, Francesca; Pezzini, Francesco; Moro, Francesca; Santorelli, Filippo M.; Simonati, Alessandro.

In: Expert Opinion on Orphan Drugs, Vol. 5, No. 6, 03.06.2017, p. 487-501.

Research output: Contribution to journalReview article

Magrinelli, Francesca ; Pezzini, Francesco ; Moro, Francesca ; Santorelli, Filippo M. ; Simonati, Alessandro. / Diagnostic methods and emerging treatments for adult neuronal ceroid lipofuscinoses (Kufs disease). In: Expert Opinion on Orphan Drugs. 2017 ; Vol. 5, No. 6. pp. 487-501.
@article{d9cfc21072f34561b1e236316397ed68,
title = "Diagnostic methods and emerging treatments for adult neuronal ceroid lipofuscinoses (Kufs disease)",
abstract = "Introduction: Adult-onset neuronal ceroid lipofuscinoses (ANCL) are a group of rare inherited neurodegenerative diseases of early adulthood, named after the presence of intralysosomal autofluorescent lipopigment with characteristic ultrastructural features in neurons and other cell types. Over the last decade, six ANCL genes have been identified, three of them being related to exclusively adult-onset phenotypes, the remaining three shared with childhood-onset NCL (CNCL). Areas covered: Even in the molecular era, the contribution of neuropathological assessment is essential since genetic heterogeneity foresees new genes to be detected and validated. No disease-modifying therapy (DMT) is available for neuronal ceroid lipofuscinoses (NCL), but patients may benefit from improved symptomatic and supportive treatments, and recent advances in cellular and molecular biology (utilizing both cellular and animal models of the disease) have provided important contributions to the knowledge of NCL pathophysiology. DMT strategies aim to prevent storage formation and/or deplete accumulated substrate; few of them have already been translated into clinical practice in CNCL only. Expert opinion: The complexity of pathophysiological mechanisms underlying NCL, such as neuronal excitotoxicity, unfavourable condition of the neuropil and enhanced vulnerability of the affected cells, requires the identification of multiple targets suitable for treatments to prevent neuronal progressive dysfunction and death.",
keywords = "Adult-onset neuronal ceroid lipofuscinosis, ANCL diagnosis, NCL, neuropathology, Parry disease, therapeutic strategies, treatment",
author = "Francesca Magrinelli and Francesco Pezzini and Francesca Moro and Santorelli, {Filippo M.} and Alessandro Simonati",
year = "2017",
month = "6",
day = "3",
doi = "10.1080/21678707.2017.1325359",
language = "English",
volume = "5",
pages = "487--501",
journal = "Expert Opinion on Orphan Drugs",
issn = "2167-8707",
publisher = "Informa Healthcare",
number = "6",

}

TY - JOUR

T1 - Diagnostic methods and emerging treatments for adult neuronal ceroid lipofuscinoses (Kufs disease)

AU - Magrinelli, Francesca

AU - Pezzini, Francesco

AU - Moro, Francesca

AU - Santorelli, Filippo M.

AU - Simonati, Alessandro

PY - 2017/6/3

Y1 - 2017/6/3

N2 - Introduction: Adult-onset neuronal ceroid lipofuscinoses (ANCL) are a group of rare inherited neurodegenerative diseases of early adulthood, named after the presence of intralysosomal autofluorescent lipopigment with characteristic ultrastructural features in neurons and other cell types. Over the last decade, six ANCL genes have been identified, three of them being related to exclusively adult-onset phenotypes, the remaining three shared with childhood-onset NCL (CNCL). Areas covered: Even in the molecular era, the contribution of neuropathological assessment is essential since genetic heterogeneity foresees new genes to be detected and validated. No disease-modifying therapy (DMT) is available for neuronal ceroid lipofuscinoses (NCL), but patients may benefit from improved symptomatic and supportive treatments, and recent advances in cellular and molecular biology (utilizing both cellular and animal models of the disease) have provided important contributions to the knowledge of NCL pathophysiology. DMT strategies aim to prevent storage formation and/or deplete accumulated substrate; few of them have already been translated into clinical practice in CNCL only. Expert opinion: The complexity of pathophysiological mechanisms underlying NCL, such as neuronal excitotoxicity, unfavourable condition of the neuropil and enhanced vulnerability of the affected cells, requires the identification of multiple targets suitable for treatments to prevent neuronal progressive dysfunction and death.

AB - Introduction: Adult-onset neuronal ceroid lipofuscinoses (ANCL) are a group of rare inherited neurodegenerative diseases of early adulthood, named after the presence of intralysosomal autofluorescent lipopigment with characteristic ultrastructural features in neurons and other cell types. Over the last decade, six ANCL genes have been identified, three of them being related to exclusively adult-onset phenotypes, the remaining three shared with childhood-onset NCL (CNCL). Areas covered: Even in the molecular era, the contribution of neuropathological assessment is essential since genetic heterogeneity foresees new genes to be detected and validated. No disease-modifying therapy (DMT) is available for neuronal ceroid lipofuscinoses (NCL), but patients may benefit from improved symptomatic and supportive treatments, and recent advances in cellular and molecular biology (utilizing both cellular and animal models of the disease) have provided important contributions to the knowledge of NCL pathophysiology. DMT strategies aim to prevent storage formation and/or deplete accumulated substrate; few of them have already been translated into clinical practice in CNCL only. Expert opinion: The complexity of pathophysiological mechanisms underlying NCL, such as neuronal excitotoxicity, unfavourable condition of the neuropil and enhanced vulnerability of the affected cells, requires the identification of multiple targets suitable for treatments to prevent neuronal progressive dysfunction and death.

KW - Adult-onset neuronal ceroid lipofuscinosis

KW - ANCL diagnosis

KW - NCL

KW - neuropathology

KW - Parry disease

KW - therapeutic strategies

KW - treatment

UR - http://www.scopus.com/inward/record.url?scp=85020093239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020093239&partnerID=8YFLogxK

U2 - 10.1080/21678707.2017.1325359

DO - 10.1080/21678707.2017.1325359

M3 - Review article

VL - 5

SP - 487

EP - 501

JO - Expert Opinion on Orphan Drugs

JF - Expert Opinion on Orphan Drugs

SN - 2167-8707

IS - 6

ER -